Table 3.
Japanese (n = 310, prevalent CACa = 36) |
Koreans (n = 294, prevalent CACa = 32) |
|||||||
---|---|---|---|---|---|---|---|---|
Adjusting covariates | 1 SD | ORb | (95% CI) | P-valuec | 1 SD | ORb | (95% CI) | P-valuec |
Age per 1SD (years) | 2.8 | 1.82 | (1.16, 2.85) | <0.01 | 2.8 | 1.01 | (0.67, 1.51) | 0.97 |
BMIa per 1SD (kg/m2) | 3.1 | 1.87 | (1.22, 2.86) | <0.01 | 2.7 | 1.56 | (1.02, 2.38) | 0.04 |
LDLc per 1SD (mmol/L) | 0.93 | 1.60 | (1.06, 2.42) | 0.02 | 0.83 | 1.54 | (1.03, 2.31) | 0.03 |
HDLc/1 SD (mmol/L) | 0.35 | 1.31 | (0.82, 2.08) | 0.26 | 0.30 | 1.10 | (0.68, 1.79) | 0.69 |
lnTG (mmol/L)/1 SD | 0.46 | 0.99 | (0.65, 1.50) | 0.95 | 0.53 | 1.17 | (0.74, 1.85) | 0.50 |
Lipid medication use | — | 2.35 | (0.46, 11.96) | 0.30 | — | 4.32 | (0.49, 37.99) | 0.19 |
Diabetes mellitus | — | 2.15 | (0.60, 7.73) | 0.24 | — | 2.58 | (0.81, 8.20) | 0.11 |
Hypertension | — | 0.66 | (0.25, 1.71) | 0.39 | — | 1.31 | (0.44, 3.87) | 0.63 |
Smoking (ref. never) | ||||||||
Past | — | 1.36 | (0.32, 5.69) | 0.68 | — | 0.74 | (0.25, 2.19) | 0.58 |
Current | — | 2.77 | (0.71, 10.81) | 0.14 | — | 0.86 | (0.29, 2.53) | 0.78 |
Alcohol drinking (ref. never) | ||||||||
Past | — | 2.33 | (0.19, 28.54) | 0.51 | — | d | (–, –) | — |
Current, <23 g/day | — | 0.60 | (0.18, 1.95) | 0.39 | — | 1.70 | (0.50, 5.78) | 0.40 |
Current, ≥23 g/day | — | 1.28 | (0.50, 3.27) | 0.61 | — | 2.22 | (0.84, 5.90) | 0.11 |
Japanese Americans (n = 299,e prevalent CACa = 95) |
US Whites (n = 308, prevalent CACa = 81) |
|||||||
Adjusting covariates | 1 SD | ORb | (95% CI) | P-valuec | 1 SD | ORb | (95% CI) | P-valuec |
Age/1 SD (years) | 2.8 | 1.50 | (1.11, 2.01) | <0.01 | 2.8 | 1.71 | (1.26, 2.32) | <0.01 |
BMI/1 SD (kg/m2) | 4.3 | 1.24 | (0.91, 1.69) | 0.18 | 4.2 | 1.70 | (1.23, 2.34) | <0.01 |
LDLc/1 SD (mmol/L) | 0.85 | 1.15 | (0.86, 1.56) | 0.35 | 0.87 | 1.28 | (0.95, 1.73) | 0.11 |
HDLc/1 SD (mmol/L) | 0.32 | 1.24 | (0.91, 1.69) | 0.18 | 0.33 | 0.77 | (0.52, 1.14) | 0.19 |
lnTG (mmol/L)/1 SD | 0.61 | 1.02 | (0.75, 1.37) | 0.92 | 0.51 | 0.83 | (0.59, 1.18) | 0.30 |
Lipid medication | — | 1.73 | (0.88, 3.43) | 0.11 | — | 3.26 | (1.47, 7.23) | <0.01 |
Diabetes mellitus | — | 1.46 | (0.66, 3.26) | 0.35 | — | 1.73 | (0.41, 7.36) | 0.46 |
Hypertension | — | 1.11 | (0.59, 2.10) | 0.74 | — | 1.16 | (0.54, 2.52) | 0.70 |
Smoking (ref. never) | ||||||||
Past | — | 1.14 | (0.60, 2.16) | 0.69 | — | 1.58 | (0.78, 3.21) | 0.21 |
Current | — | 2.64 | (1.21, 5.74) | 0.01 | — | 2.08 | (0.73, 5.90) | 0.17 |
Alcohol drinking (ref. never) | ||||||||
Past | — | 1.08 | (0.48, 2.42) | 0.86 | — | 0.82 | (0.28, 2.41) | 0.72 |
Current, <23 g/day | — | 0.84 | (0.32, 2.25) | 0.73 | — | 0.97 | (0.48, 1.94) | 0.93 |
Current, ≥23 g/day | — | 1.75 | (0.90, 3.37) | 0.10 | — | 1.17 | (0.49, 2.82) | 0.72 |
BMI, body mass index; CAC, coronary artery calcium; HDLc, high-density lipoprotein cholesterol; LDLc, low-density lipoprotein cholesterol; lnTG, natural log-transformed value of triglycerides; OR, odds ratio; SD, standard deviation; 95% CI, 95% confidence interval.
aPrevalent CAC was defined as the Agatston score ≥10.
bFor a continuous variable, odds ratio was expressed/1 SD (ethnic group-specific SD) increase in the value.
Odds ratio was adjusted for age (years), serum levels (continuous) of LDLc, HDLc, and lnTG, use of lipid medication (yes/no), diabetes mellitus (yes/no), hypertension (yes/no), smoking (never, past, and current), and alcohol drinking (never, past, current <23 g/day, current ≥23 g/day) (Model 4). Diabetes mellitus was defined as the use of anti-diabetic medication(s) or fasting glucose ≥7.0 mmol/L (126 mg/dL). Hypertension was defined as the use of anti-hypertensive medication(s) or systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg.
cP-values were two-sided.
dThe estimates were unable to obtain because no participants in this category had prevalent CAC.
eOne participant was excluded in this analysis due to missing HDLc.